Abstract
Photodynamic therapy (PDT) is a selective, experimental treatment for solid tumors. PDT consists of the activation of a photosensitizing agent by light. The photodynamic reaction induced by light causes damage to the tissue containing the photosensitizer in the presence of oxygen. The idea of treating tumors by photosensitizers is as old as the early 1900s; already in 1903, topic application of eosin and exposition to sunlight was known to produce a response in skin tumors. Later, in 1924, Policard reported reddish fluorescence in animal and human tumors observed under Wood lamp. The presence of fluorescence was attributed to endogenous porphyrins accumulated after infection of the observed tissue by hemolytic bacteria.2 In 1942, Auler and Banzer3 reported animal tumor fluorescence after systemic administration of Hematoporphyrin (HP) and in 1960 Lipson and coworkers prepared the Hematoporphyrine derivative (HPD), a mixture of porphyrins obtained by treating HP with acetic and sulphuric acids.4 They demonstrated that HPD was selectively accumulated by malignant as well as by actively proliferating tissues and produced the first demonstration of endoscopic diagnosis of malignant tissues by detection of fluorescence in the respiratory and in the upper digestive tract.5 After the development of the laser, diagnosis through fluorescence and particularly PDT have been studied further.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
H. Tappenier, A. Jesionek, Therapeutische versuche mit fluoreszierenden Stoffe, Muench. Med. Wochenschr. 1:2042 (1903),
A. Policard, Etudes sur les aspects offerts par des tumeurs experimentales éxaminées à la lumière de Woods, Cr. Soc. Biol. 91:1423 (1924).
H. Auler and G. Banzer, Untersuchungen uber die rolle der porphine bei geschwulstkranken menschen und tieren, Z. Krebsforsch. 53:65 (1942).
R. L. Lipson and E. J. Baldes, The photodynamic properties of a particular hematoporphyrin derivative, Arch. Dermatol. 82:508 (1960).
R. L. Lipson, E. J. Baldes and A. M. Olsen, Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease, J. Thorac. Cardiovasc. Surg. 42:623 (1961).
J. Moan, Porphyrin-sensitized photodynamic inactivation of cells: a review, Lasers Med. Sci. 1:5 (1986).
R. Hilf, D. B. Smail, R. S. Murant, et al., Hematoporphyrin derivative-induced photosensitivity of mitochondrial succinate dehydrogenase and selected cytosolic enzymes of R3230 AC mammary adenocarcinomas of rats, Cancer Res. 44:1483 (1984).
C. J. Gomer, DNA damage and repair in CHO cells following hematoporphyrin photoradiation, Cancer Lett. 11:161 (1980).
T. J. Dougherty, Photodynamic therapy (PDT) of malignant tumors, CRC Crit. Rev. Oncol/Haemat. 2:83 (1985).
T. J. Dougherty, W. R. Potter, and K. R. Weishaupt, The structure of the active component of hematoporphyrin derivative, in: “Porphyrin localization and treatment of tumors,” D. R. Doiron and C.J. Gomer, eds., Alan R. Liss, Inc., New York (1984).
G. Jori, Pharmacokinetics studies with hematoporphyrin in tumor-bearing mice, in: “Photodynamic Therapy of Tumors and other Diseases,” G. Jori and C. Perria, eds., Progetto Publ., Padova (1985).
D. Mew, C. K. Wat, G. H. N. Towers, and J. G. Levy, Photoimmunotherapy: treatment of animal tumors with tumor specific monoclonal antibody-hematoporphyrin conjugates, J. Immunol. 130:1473 (1983).
R. Kol, E. Ben-Hur, E. Riklis, R. Marko, and I. Rosenthal, Photosensitized inhibition of mitogenic stimulation of human lymphocytes by aluminium phthalocyanine tetrasulphonate, Lasers Med. Sci. 1:187 (1986).
A. M. Richter, E. Sternberg, E. Waterfield, D. Dolphin, and J. G. Levy, Characterization of benzoporphyrin derivative, a new photosensitizer, Proc. SPIE 997:132 (1988).
T. J. Dougherty, J. E. Kaufman, A. Goldfarb, K. R. Weishaupt, D. G. Boyle, and A. Mittleman, Photoradiation therapy for the treatment of malignant tumors Cancer Res. 38:2628 (1978).
P. Spinelli and M. Dal Fante, Photodynamic therapy in G.I. tract, Acta Endosc. 15:69 (1985).
J. A. Parrish, “Photomedicine potential for lasers. An overview from lasers in photomedicine and photobiology,” R. Pratesi and C.A. Sacchi, eds., Springer-Verlag, Berlin (1980).
A. L. Mc Kenzie and J. A. S. Carruth, A comparison of gold-vapour and dye lasers for PDT, Lasers Med. Sci. 1:117 (1986).
T. J. Dougherty, Photodynamic therapy — New approaches, Sem. Surg. Oncol. 5:6 (1989).
R. Brancato, L. Giovannoni, R. Pratesi, and U. Vanni, New lasers for ophthalmology: retinal photocoagulation with pulsed diode lasers, Proc. SPIE 701:365 (1986).
P. Spinelli and M. Dal Fante, Contact laser endoscopic surgery with sapphire microprobes, Proc. SPIE 701:331 (1986).
V. Russo, Optical fiber delivery systems for laser medical applications, in: “Photodynamic Therapy of Tumors and other Diseases,” G. Jori and C. Perria, eds., Progetto Publ., Padova (1985).
Y. Hayata, H. Kato, C. Konaka, J. Ono, and N. Takizawa, Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer, Chest 81:269 (1981).
P. Spinelli and M. Dal Fante, PDT — State of the art, in: “Laser Optoelectronics in Medicine,” W. Waidelich and P. Kiefhaber, eds., Springer-Verlag, Berlin (1987).
P. Spinelli, S. Andreola, R. Marchesini, E. Melloni, V. Mirabile, P. Pizzetti, and F. Zunino, Endoscopic HpD-laser photoradiation therapy (PRT) of cancer, in: “Porphyrins in tumor phototherapy,” A. Andreoni and R. Cubeddu, eds., Plenum Publishing Corporation, (1984).
J. T. Allardice, A. C. Rowland, N. S. Williams, and C. P. Swain, A new light delivery system for the treatment of obstructing gastrointestinal cancers by photodynamic therapy, Gastrointest. Endosc. 35:548 (1989).
Japanese Study for Gastroenterological Endoscopy, in: “T. Murakami, Pathomorphological diagnosis, definition and gross classification of early gastric cancer, T. Murakami, ed., University of Tokyo Press, Tokyo (1971).
M. Dal Fante, G. Bottiroli, and P. Spinelli, Behaviour of haematoporphyrin derivative in adenomas and adenocarcinomas of the colon: a microfluorometric study, Lasers Med. Sci. 3:165 (1988).
R. M. Cothren, R. Richards-Kortum, M. V. Sivak, Jr., et al., Gastrointestinal tissue diagnosis by laser-induced fluorescence spectroscopy at endoscopy, Gastrointest. Endosc. in press.
E. M. H. Mathus-Vliegen and G. N. J. Tytgat, Nd: YAG laser photocoagulation in colorectal adenoma. Evaluation of its safety, usefulness, and efficacy, Gastroenterol. 90:1865 (1986).
H. Kato, C. Konaka, J. Ono, et al., Preoperative laser photodynamic therapy in combination with operation in lung cancer, J. Thorac. Cardiovasc. Surg. 90:420 (1985).
R. C. Benson, Jr., Laser photodynamic therapy for bladder cancer. Mayo. Clin. Proc. 61:859 (1986).
D. Jocham, G. Staehler, C. Chaussy, et al., Integral dye-laser irradiation of photosensitized bladder tumors with the aid of a light-scattering medium, Prog. Clin. Biol. Res. 170:249 (1984).
H. Tajiri, N. Daizukono, S. N. Joffe, and Y. Oguro, Photoradiation therapy in early gastrointestinal cancer, Gastrointest. Endosc. 33:88 (1987).
J. S. Mc Caughan, T. E. Williams, and B. H. Bethel, Palliation of esophageal malignancy with photodynamic therapy, Am. Thorac. Surg. 40:113 (1985).
M. Nishizawa, T. Okada, T. Hosoi, et al., Detecting early esophageal cancers, with special reference to the intraepithelial stage, Endoscopy 16:92 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Spinelli, P., Dal Fante, M., Mancini, A. (1991). Laserchemotherapy of Tumours: Clinical Aspects. In: Pratesi, R. (eds) Optronic Techniques in Diagnostic and Therapeutic Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3766-3_20
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3766-3_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6678-2
Online ISBN: 978-1-4615-3766-3
eBook Packages: Springer Book Archive